Score Overview
Explore the 2021 public Archive ranking →
Where Ironwood Pharmaceuticals Inc has ranked, year by year
Showing 10 years ranking history by Net Income Consistency.
Has not reached the top 50 on Net Income Consistency in any year we have ranked.
- IRWD
2020: 89.3% · 2021: 92.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-22 | $ 3.57 | — |
1 Year2025-10-22 | $ 1.57 | 127.39% |
5 Years2021-10-22 | $ 13.03 | -72.60% |
10 Years2016-10-21 | $ 11.54 | -69.07% |
All Time2010-02-03 | $ 9.75 | -63.39% |
| Period | Last Price2026-10-22 | 1 Year2025-10-22 | 5 Years2021-10-22 | 10 Years2016-10-21 | All Time2010-02-03 |
|---|---|---|---|---|---|
| Price | $ 3.57 | $ 1.57 | $ 13.03 | $ 11.54 | $ 9.75 |
| Return | — | 127.39% | -72.60% | -69.07% | -63.39% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 389M | $ 129M | $ 79M |
| 2025 | $ 296M | $ 24M | $ 215M |
| 2024 | $ 351M | $ 88M | |
| 2023 | $ 442M | -$ 1.00B | $ 92M |
| 2022 | $ 410M | $ 175M | $ 656M |
| 2021 | $ 413M | $ 528M | $ 620M |
| 2020 | $ 389M | $ 106M | $ 364M |
| 2019 | $ 428M | $ 21M | $ 177M |
| 2018 | $ 346M | -$ 282M | $ 173M |
| 2017 | $ 298M | -$ 116M | $ 221M |
| 2016 | $ 273M | -$ 81M | $ 305M |
| 2015 | $ 149M | -$ 142M | $ 439M |
| 2014 | $ 76M | -$ 189M | $ 248M |
| 2013 | $ 22M | -$ 272M | $ 197M |
| 2012 | $ 150M | -$ 72M | $ 168M |
| 2011 | $ 65M | -$ 64M | $ 164M |
| IPO2010 | $ 43M | -$ 52M | $ 248M |
Ironwood Pharmaceuticals Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 149M to $ 296M and net income went from -$ 142M to $ 24M. Revenue increased in 6 of those 10 years; net income in 5.
Across Ironwood Pharmaceuticals Inc's full reported history, from 2010 to 2025, revenue grew from $ 43M to $ 296M and net income went from -$ 52M to $ 24M. Revenue increased in 69% of the years measured; net income in 50%.
Ironwood Pharmaceuticals Inc currently holds a 5-year HDB Score of 3.0 out of 10. How the HDB Score is calculated.
Membership
Continue IRWD’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,119 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
